MIT develops nanoparticles to enable MRI, fluorescent imaging

Chemists at the Massachusetts Institute of Technology (MIT) have developed nanoparticles that could eventually help track disease progression.

The particles have distinct sensors for fluorescence and MRI. For example, the researchers have shown that high concentrations of vitamin C result in a strong fluorescent signal, while a stronger MRI signal is visible with lower amounts of vitamin C. For more on this research, check out the article from MIT News at the link below: 

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.